Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective

por De Block, Christophe, Bailey, Clifford, Wysham, Carol, Hemmingway, Andrea, Allen, Sheryl Elaine, Peleshok, Jennifer
Publicado 2022

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program

por Allen, Sheryl Elaine, Cheng, Alice, Choudhary, Pratik, Levine, Joshua A, Ranta, Kari, Thieu, Vivian Thuyanh, Valderas, Elisa Gomez, Lingvay, Ildiko
Publicado 2022